Pricing Log in Create free account

MannKind Corporation (MNKD) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

MannKind Corporation and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. MannKind Corporation and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.1B and $1.0B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 16 metrics below, MannKind Corporation leads on 11 and Nanobiotix S.A. - Sponsored ADR on 5.

Valuation

Metric MNKD NBTX Biotechnology median
P/E n/m n/m 8.50
P/S 2.39 4,254.38 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 39.75 n/m 0.64
EV/Sales 3.18 3,498.88 9.21
Earnings yield (4.28%) (15.59%) (33.15%)
Free cash flow yield (1.93%) (19.65%) (25.50%)

Profitability

Metric MNKD NBTX Biotechnology median
Gross margin 75.39% 0.00% 65.16%
Operating margin 2.34% 0.00% 0.00%
Net margin (11.08%) 0.00% 0.00%
Free cash flow margin (4.61%) 0.00% 0.00%
Return on equity 71.36% 0.00% (56.36%)
Return on assets (7.62%) 0.00% (48.04%)
Return on invested capital 2.36% 0.00% 0.00%

Growth

Metric MNKD NBTX Biotechnology median
Revenue growth (TTM) 30.46% — 6.02%
EPS growth (last fiscal year) (80.00%) 63.46% 30.26%
Revenue growth, 5-year CAGR 39.89% 66.64% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNKD NBTX Biotechnology median
Debt to equity (6.28) 0.00 0.00
Current ratio 1.72 1.44 4.72
Net debt to EBITDA 5.32 5.66 0.96

Dividend

Metric MNKD NBTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MNKD NBTX Biotechnology median
Market cap 1.03b 1.13b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack